Position Statement on Compliance with Information Standards Notice (DAPB4013 Amd 5/2021)
A position statement has been added to the Customer Area – Technical & Clinical Information.
This document describes the impact of Information Standards Notice (DAPB4013 Amd 5/2021) on ChemoCare users and how CIS Oncology will enable users to comply with this standard with current installations of ChemoCare. The Information Standards Notice (ISN) requires that if there is an existing electronic flow of medication and allergy/intolerance information then it must comply with the requirements of the ISN by 31 March 2023. Any new electronic flows introduced from that date onwards must also be compliant.